Free Trial

MIRA Pharmaceuticals (MIRA) SEC Filings & 10K Form

MIRA Pharmaceuticals logo
$1.50 +0.03 (+2.04%)
Closing price 08/15/2025 04:00 PM Eastern
Extended Trading
$1.48 -0.02 (-1.33%)
As of 08/15/2025 07:59 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Recent MIRA Pharmaceuticals SEC Filings

DateFilerForm TypeView
08/12/2025
7:00 AM
MIRA Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/08/2025
4:15 PM
MIRA Pharmaceuticals (Filer)
Form DEFA14A
08/08/2025
4:15 PM
MIRA Pharmaceuticals (Filer)
Form DEFM14A
07/29/2025
4:26 PM
MIRA Pharmaceuticals (Filer)
Form PRER14A
07/28/2025
3:01 PM
MIRA Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/10/2025
3:19 PM
MIRA Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/08/2025
4:25 PM
MIRA Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/30/2025
6:30 AM
MIRA Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/24/2025
3:01 PM
MIRA Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/17/2025
7:01 AM
MIRA Pharmaceuticals (Filer)
Form PREM14A
06/10/2025
6:12 AM
MIRA Pharmaceuticals (Issuer)
Weichselbaum Alan (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
05/28/2025
7:00 AM
MIRA Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/21/2025
4:25 PM
MIRA Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/08/2025
6:30 AM
MIRA Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/06/2025
6:30 AM
MIRA Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/23/2025
6:30 AM
MIRA Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/17/2025
4:28 PM
MIRA Pharmaceuticals (Filer)
Form 10-K/A
04/16/2025
4:17 PM
MIRA Pharmaceuticals (Filer)
Form 424B5
04/16/2025
6:30 AM
MIRA Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/15/2025
4:15 PM
MIRA Pharmaceuticals (Filer)
Form 10-K/A
04/11/2025
4:15 PM
MIRA Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/01/2025
6:30 AM
MIRA Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/24/2025
6:30 AM
MIRA Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/13/2025
6:45 AM
MIRA Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/04/2025
7:00 AM
MIRA Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/20/2024
4:00 PM
MIRA Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/19/2024
7:30 AM
MIRA Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/10/2024
4:15 PM
Del Giudice Matthew Paul (Reporting)
MIRA Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/10/2024
4:15 PM
MIRA Pharmaceuticals (Issuer)
Shekhat Denil Nanji (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/10/2024
4:15 PM
Aminov Erez (Reporting)
MIRA Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/10/2024
4:15 PM
MIRA Pharmaceuticals (Issuer)
Yanez Michelle (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/10/2024
4:15 PM
MacPherson Edward Clouston (Reporting)
MIRA Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/10/2024
4:15 PM
MIRA Pharmaceuticals (Issuer)
Whalen Matthew Pratt (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/10/2024
7:45 AM
MIRA Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/27/2024
3:15 PM
Aminov Erez (Reporting)
MIRA Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/19/2024
4:58 PM
Aminov Erez (Reporting)
MIRA Pharmaceuticals (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
10/21/2024
6:00 AM
MIRA Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/27/2024
4:20 PM
MIRA Pharmaceuticals (Filer)
Form 424B5
09/27/2024
3:45 PM
MIRA Pharmaceuticals (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
09/12/2024
3:30 PM
MIRA Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/10/2024
3:01 PM
MIRA Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
Generate up to $5,000/month with 10X less money? (Ad)

The secret to retiring without a million-dollar nest egg. I'm talking about generating enough monthly income to cover housing, healthcare, food, and fun... With a fraction of what you probably think you need.

Here's the secret to retiring without a million-dollar nest egg →
09/06/2024
3:38 PM
McNulty Brian Patrick (Reporting)
MIRA Pharmaceuticals (Subject)
Form 144/A
09/04/2024
7:20 PM
McNulty Brian Patrick (Reporting)
MIRA Pharmaceuticals (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
08/18/2024
11:15 PM
MIRA Pharmaceuticals (Filer)
Form EFFECT
(Data available from 1/1/2016 forward)


Related Companies and Tools


This page (NASDAQ:MIRA) was last updated on 8/16/2025 by MarketBeat.com Staff
From Our Partners